Cellular, Tissue and Gene Therapies Advisory Committee

November 20, 2006 Meeting

Date and Time: The meeting will be held by teleconference on November 20, 2006 from 2:15 pm to approximately 5 pm.

Location: National Institutes of Health, Building 29, Room 121, 9000 Rockville Pike, MD. This meeting will be held by teleconference. The public is welcome to attend the meeting at the specified location. A speakerphone will be provided at the specified location for public participation in the meeting.

Contact Person: Gail Dapolito or Rosanna Harvey, Center for Biologics Evaluation and Research, (HFM-71), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD, 20852, 301- 827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3-14512389. Please call the Information Line for up-to-date information on this meeting.

Agenda: On November 20, 2006 the Committee will meet in open session to hear updates of research programs in the Laboratory of Immunobiology and the Laboratory of Immunology, Office of Biotechnology Products, Center for Drug Evaluation and Research.

Oral presentations from the public will be scheduled between approximately 3:30 pm and 4:30 pm.

Closed Committee Deliberations: On November 20, 2006 from approximately 4:30 pm to 5 pm, the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)). The Committee will discuss a report of intramural research programs.

 
Updated: November 7, 2006